TCON - PRICE - TRACON Pharmaceuticals

This TCON price chart illustrates the performance of TRACON Pharmaceuticals (TCON), a company developing precision treatments for rare cancers that has earned expert recognition for the quality of its tests. The operating model relies on engaging external CROs for early-stage research, which mitigates the risks of dependency on a single contractor. The current metric stands at , while the business implements eco-standards to minimize harmful laboratory emissions.

The price reflects the asset's market value and serves as an indicator of compliance with US exchange listing requirements regarding minimum capitalization. For TRACON Pharmaceuticals (TCON), the price history becomes a measure of regulatory risks amid the cessation of research and workforce reductions, turning the chart into a monitor for the liquidation process or the sale of patent rights.